Center News

Memorial Sloan-Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

December 15, 2011
Pictured: Robert Motzer

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate, the side effects of other approved drugs for the disease.

February 7, 2012
Pictured: Memorial Sloan-Kettering logo

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

February 6, 2012
Pictured: Charles Sawyers & Howard Scher

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

February 3, 2012
Pictured: Marc Ladanyi & Laetitia Borsu

Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

February 1, 2012
Pictured: Monica Morrow

Breast Surgical Service Chief, Monica Morrow, provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

January 31, 2012
Pictured: Stephanie Luedke

While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.

January 30, 2012

Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.

January 25, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan-Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

January 23, 2012
Pictured: Eric Pamer

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan-Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

January 20, 2012
Pictured: Michael Quinlan

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan-Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

January 19, 2012
Center News Magazine

Newsroom for Journalists »

Looking for an expert? Need background information or story ideas? We can help.

Subscribe to Our E-newsletter »

Get the latest information about cancer care and research via e-mail.

Subscribe